Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_assertion type Assertion NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_head.
- NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_assertion description "[In conclusion, these data suggest that elevated ODC and low OAZ2 mRNA expression levels correlate with several unfavorable genetic and clinical features in NB, offering new insights into PA pathways and PA metabolism-targeting therapy in NB.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_provenance.
- NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_assertion evidence source_evidence_literature NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_provenance.
- NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_assertion SIO_000772 19960435 NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_provenance.
- NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_assertion wasDerivedFrom befree-20150227 NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_provenance.
- NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_assertion wasGeneratedBy ECO_0000203 NP601428.RA-ij5Arq6ehb_Ll_OknIMzlNCK0bo-vy9SuvUF14tkrI130_provenance.